According to the report by Allied Market Research, titled, “Generic Injectable Market by Product Type (Monoclonal Antibodies, Cytokines, Insulin, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Infections, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Stores, and Online Prescription Stores): Global Opportunity Analysis and Industry Forecast, 2021โ2030”. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.
A generic injectable is a drug that has the same active pharmaceutical ingredient as its branded counterpart. A generic injectable is also equivalent to its branded counterpart in safety, strength, dosage form, performance, quality, and route of administration. Unlike branded injectable drugs, generic injectable has lower costs especially the ones used for cancer therapies. This is the reason why governments in many countries are focused on adopting generic injectable to help control healthcare spending. In addition, generic injectable has a high margin and low R&D investments.
Request The Free Sample PDF Of This Report:
https://www.alliedmarketresearch.com/request-sample/11917
Comprehensive competitive analysis and profiles of major market players, such as
Pfizer, Inc., Baxter International, Sanofi SA, Novartis AG (Sandoz), GlaxoSmithKline Plc., AstraZeneca plc., Fresenius SE & Co. KGaA, Johnson & Johnson, Novo Nordisk A/S, Amgen Inc., and Bristol-Myers Squibb Company
Key Benefits For Stakeholders:
- With increase in drug shortage, especially in the U.S., governments in many countries are supporting the manufacture of generic injectable as they do not come with patents.
- The rise in aging population and increase in cases of chronic diseases are also some of the factors that have led to shortage of injectable. This, in turn, helps to increase the demand for generic injectable.
- The R&D cycles of generic drugs are shorter as they are the bio-equivalents of their branded counterparts. This offers the advantage of saving time to the manufacturers and is helps boost the growth of the generic injectable market.
- The expiry of patents of branded injectable and less number of new launches are among the factors that have contributed to the growth of the generic injectable market.
- However, the manufacturing of generic injectable is quite complex. With the lack of a skilled workforce in many developing countries, this can act as a restraint for the generic injectable market.
๐๐ฒ๐ ๐ฑ๐ฒ๐๐ฎ๐ถ๐น๐ฒ๐ฑ ๐๐ข๐ฉ๐๐-๐ญ๐ต ๐ถ๐บ๐ฝ๐ฎ๐ฐ๐ ๐ฎ๐ป๐ฎ๐น๐๐๐ถ๐@ ๐ฅ๐ฒ๐พ๐๐ฒ๐๐ ๐๐ผ๐ฟ ๐๐๐๐๐ผ๐บ๐ถ๐๐ฎ๐๐ถ๐ผ๐ป: https://www.alliedmarketresearch.com/request-for-customization/11917
Table of Content:
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING
3.4. PORTERโS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunitiesโฆ
Q8. What are the key trends in the Lab-on-Chip Market report?
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
โWe have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.โ
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with vario research data tables and confirms utmost accuracy in our market forecasting. Each and ever us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com